Hemab Therapeutics HoldingsCOAG

ListedNasdaq

Road to listing

Filed (S-1)04/10
3 amendments04/30
Last amendment
Declared effective04/30
Priced04/30
Listed05/01
Lock-up ends07/30
Passed

Offering terms

Offer price: $18.00
Shares offered: 16,750,000 sh
Raised: $301.5M
Exchange: Nasdaq
Lock-up: 90 days · prospectus

Hemab Therapeutics Holdings stock pagePrice and every trade

5% holders

			Form
Ra Capital Management	16.6%	7,729,773 sh	13G passive	05/11
AI Den-Mab	10.4%	4,876,344 sh	13D	05/11
Novo Holdings A/S	9.0%	4,180,550 sh	13G passive	08/14
Deep Track Capital	8.2%	3,600,996 sh	13G passive	05/08
FMR	7.9%	3,697,837 sh	13G passive	08/06
Capital International Investors	7.7%	3,603,876 sh	13G passive	08/12
Avoro Capital Advisors	7.1%	3,298,236 sh	13G passive	08/14
Crossover S.L.P. Sofinnova II	5.4%	2,511,212 sh	13G passive	08/05
Invus Global Management	5.1%	2,366,235 sh	13G passive	08/07

Filings

424B4 final prospectus05/01
EFFECT notice of effectiveness04/30
S-1/A amendment04/30
S-1/A amendment04/28
8-A12B exchange registration04/27
S-1/A amendment04/27
S-1 registration statement04/10

Hemab Therapeutics Holdings COAG US IPO: offer price, listing date, lock-up expiry | Whalegun